AAAAAA

   
Results: 1-13 |
Results: 13
Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain
Authors: Cocuzza, AJ Chidester, DR Cordova, BC Jeffrey, S Parsons, RL Bacheler, LT Erickson-Viitanen, S Trainor, GL Ko, SS
Citation: Aj. Cocuzza et al., Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain, BIOORG MED, 11(9), 2001, pp. 1177-1179
Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz
Authors: Markwalder, JA Mutlib, DDCA Cordova, BC Klabe, RM Seitz, SP
Citation: Ja. Markwalder et al., Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz, BIOORG MED, 11(5), 2001, pp. 619-622
Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase
Authors: Corbett, JW Kresge, KJ Pan, SL Cordova, BC Klabe, RM Rodgers, JD Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase, BIOORG MED, 11(3), 2001, pp. 309-312
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors
Authors: Corbett, JW Pan, SL Markwalder, JA Cordova, BC Klabe, RM Garber, S Rodgers, JD Erickson-Viitanen, SK
Citation: Jw. Corbett et al., 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors, BIOORG MED, 11(2), 2001, pp. 211-214
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Bacheler, LT Erickson-Viitanen, S Rodgers, JD
Citation: M. Patel et al., Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 11(14), 2001, pp. 1943-1945
4,1-Benzoxazepinone analogues of efavirenz (Sustiva (TM)) as HIV-1 reversetranscriptase inhibitors
Authors: Cocuzza, AJ Chidester, DR Cordova, BC Klabe, RM Jeffrey, S Diamond, S Weigelt, CA Ko, SS Bacheler, LT Erickson-Viitanen, SK Rodgers, JD
Citation: Aj. Cocuzza et al., 4,1-Benzoxazepinone analogues of efavirenz (Sustiva (TM)) as HIV-1 reversetranscriptase inhibitors, BIOORG MED, 11(11), 2001, pp. 1389-1392
Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors
Authors: Corbett, JW Gearhart, LA Ko, SS Rodgers, JD Cordova, BC Klabe, RM Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors, BIOORG MED, 10(2), 2000, pp. 193-195
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Rodgers, JD
Citation: M. Patel et al., Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 10(15), 2000, pp. 1729-1731
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors
Authors: Corbett, JW Ko, SS Rodgers, JD Gearhart, LA Magnus, NA Bacheler, LT Diamond, S Jeffrey, S Klabe, RM Cordova, BC Garber, S Logue, K Trainor, GL Anderson, PS Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 43(10), 2000, pp. 2019-2030
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents
Authors: Patel, M Rodgers, JD McHugh, RJ Johnson, BL Cordova, BC Klabe, RM Bacheler, LT Erickson-Viitanen, S Ko, SS
Citation: M. Patel et al., Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents, BIOORG MED, 9(22), 1999, pp. 3217-3220
Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA (TM))
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Ko, SS
Citation: M. Patel et al., Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA (TM)), BIOORG MED, 9(22), 1999, pp. 3221-3224
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA (TM)) as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M Ko, SS McHugh, RJ Markwalder, JA Srivastava, AS Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Seitz, SP
Citation: M. Patel et al., Synthesis and evaluation of analogs of Efavirenz (SUSTIVA (TM)) as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 9(19), 1999, pp. 2805-2810
Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1 ' substituents
Authors: Kaltenbach, RF Klabe, RM Cordova, BC Seitz, SP
Citation: Rf. Kaltenbach et al., Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1 ' substituents, BIOORG MED, 9(15), 1999, pp. 2259-2262
Risultati: 1-13 |